AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

BETAHISTINE

15 registrations across 5 African markets— 12 active

Markets with BETAHISTINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
BETASERC 24MG COMPRIME BOITE DE 60🇨🇮Côte d'IvoireABBOTTactiveDec 2026
BETASERC
Comprimé sécable / 24 mg
🇹🇳TunisiaTERIAKexpiredSept 2007
BETAGAM
Comprimé / 8 MG
🇹🇳TunisiaPHARMAGHREBexpiredNov 2004
SERC
Comprimé / 8 MG
🇹🇳TunisiaTERIAKexpiredNov 2001
BETASERC 24 CP(60) MYLAN MEDICAL SAS
comprimé 24mg (60)
🇲🇬MadagascarMYLAN MEDICAL SAS 40-44active
BETASERC 24 MG
COMPRIME
🇲🇦Moroccoactive
LECTIL 16 MG
COMPRIME SECABLE
🇲🇦Moroccoactive
BETASERC 24 CP(60) MYLAN MEDICAL SAS
comprimé 24mg (60)
🇲🇬MadagascarMYLAN MEDICAL SAS 40-44active
Anatax
Tablets
🇹🇿TanzaniaUNITED PHARMACEUTICALS MANUFACTURING LIMITED COMPANYactive
BE - Stedy 16
Tablets
🇹🇿TanzaniaAurobindo Pharma Limitedactive
Betaserc
Tablets
🇹🇿TanzaniaAbbott Laboratories S.A (Pty) Ltdactive
SERC
COMPRIME
🇲🇦Moroccoactive
BETASERC 24 MG
COMPRIME
🇲🇦Moroccoactive
VERTIS
COMPRIME
🇲🇦Moroccoactive
Be-stedy 8
Tablets
🇹🇿TanzaniaAurobindo Pharma Limitedactive

BETAHISTINE in Africa — Regulatory Overview

BETAHISTINE is registered across 5 African markets with 15 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Tanzania, Tunisia, Madagascar and 1 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 15 registrations, 12 (80%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.